News | 28 July 2022
Velocity Clinical Research begins European expansion with German site acquisition
Biopharma and CROs to benefit from simplified access to global research sites
Biopharma and CROs to benefit from simplified access to global research sites
Dr. Lal Path Labs has reported total income of Rs. 511 crores during the period ended June 30, 2022
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Sanofi India has reported total income of Rs. 715 crores during the period ended June 30, 2022.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
WuXi STA opens a new large scale continuous manufacturing plant
Better serving global partners and advancing healthcare innovation
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Subscribe To Our Newsletter & Stay Updated
